RBS supports Abcam Plcs acquisition of Epitomics
Royal Bank of Scotland Corporate & Instituational Banking (RBS CIB) is delighted to announce its financial support for Abcam Plc by arranging a committed £20m revolving credit facility (RCF), provided on a bilateral basis, to enable the group to finance the cross-border acquisition of Epitomics International Inc, headquartered in San Francisco, California.
14 May 2012
Headquartered in Cambridge, UK, Abcam is a global, leading online supplier of research grade antibodies and reagents, with a catalogue of over 80,000 products.
The £20m RCF from Royal Bank of Scotland was coordinated by Mark Trainor, director, Structured Finance Corporates at RBS CIB, and Ed Urbas, relationship director at RBS CIB.
"The acquisition of Epitomics is an excellent strategic fit for Abcam, adding to the strength and breadth of our business. RBS played an important role in enabling the acquisition to be delivered, and we value their continued support."
Jeff Iliffe, Abcam’s CFO
"RBS has been delighted to support Abcam since its early days, and this finance package reaffirms RBS' commitment to support the group's continued growth strategy, and we look forward to being part of the business' ongoing development."
Mark Trainor, director, Structured Finance Corporates at RBS CIB
Posted In
Tagged
Latest news
RBS has today committed to helping 2.5 million people in the UK each year to improve their financial capability.
RBS has executed a £1.1bn securitisation deal with Macquarie Infrastructure Debt Investment Solutions (MIDIS), which will allow the bank to recycle capital and increase lending to the sustainable or renewable energy sectors.
RBS has today announced a new £1 billion in funding through NatWest to support female entrepreneurs in the UK to scale and grow – the largest intervention by a UK lender focused specifically on female-led businesses.